先进制造业知识服务平台
国家科技图书文献中心机械分馆 工信部产业技术基础公共服务平台 国家中小企业公共服务示范平台
主页
外文期刊
OA 期刊
外文会议
标准
网络数据库
专业机构
高级检索
关于我们
版权声明
使用帮助
OA期刊
ISSN
1942-0862
刊名
Mabs
出版商
Taylor & Francis Inc.
url
https://www.tandfonline.com/loi/kmab20
机构
Taylor & Francis Ltd.
全部
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2024, vol.16, no.1
2024, vol.16, no.10
2024, vol.16, no.11
2024, vol.16, no.12
2024, vol.16, no.2
2024, vol.16, no.3
2024, vol.16, no.4
2024, vol.16, no.5
2024, vol.16, no.6
2024, vol.16, no.7
2024, vol.16, no.8
2024, vol.16, no.9
题名
作者
出版年
年卷期
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
Tushar Jain;Bianka Prinz;Alexander Marker;Alexander Michel;Katrin Reichel;Valerie Czepczor;Sylvie Klieber;Wei Sun;Sagar Kathuria;Sevim Oezguer Bruederle;Christian Lange;Lena Wahl;Charles Starr;Alessandro Masiero;Lindsay Avery;
2024
2024, vol.16, no.7
Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations
Joel Heisler;Daniel Kovner;Saeed Izadi;Jonathan Zarzar;Paul J. Carter;
2024
2024, vol.16, no.7
Identification of novel anti-CD16a antibody clones for the development of effective natural killer cell engagers
2024
2024, vol.16, no.7
Rapid depletion of “catch-and-release” anti-ASGR1 antibody in vivo
Siva Charan Devanaboyina;Peng Li;Edward L. LaGory;Carrie Poon-Andersen;Kevin D. Cook;Marcus Soto;Zhe Wang;Khue Dang;Craig Uyeda;Ryan B. Case;Veena A. Thomas;Ronya Primack;Manuel Ponce;Mei Di;Brian Ouyang;Joelle Kaner;Sheung Kwan Lam;Mina Mostafavi;
2024
2024, vol.16, no.7
Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy
Patrizia Murer;Barbara Brannetti;Jean-Michel Rondeau;Laetitia Petersen;Nicole Egli;Simone Popp;Catherine Regnier;Kirsten Richter;Andreas Katopodis;Christoph Huber;
2024
2024, vol.16, no.7
Quantifying LAGA mutated mouse IgG2a monoclonal antibody with a rapid pepsin digestion enabled immunoaffinity LC/MS/MS assay
Linlin Dong;Susan Chen;Konstantin Piatkov;Dong Wei;Mark G. Qian;
2024
2024, vol.16, no.7
Illuminating a biologics development challenge: systematic characterization of CHO cell-derived hydrolases identified in monoclonal antibody formulations
Melanie Maier;Linus Weiß;Nikolas Zeh;Valerie Schmieder-Todtenhaupt;Alireza Dehghani;Marius Nicolaus Felix;Daniel Heinzelmann;Benjamin Lindner;Moritz Schmidt;Joey Studts;Patrick Schulz;Bernd Reisinger;Kerstin Otte;Matthias Franzreb;Daniel Lakatos;Simon Fischer;
2024
2024, vol.16, no.7
Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy
Amelia C. McCue;Stephen J. Demarest;Karen J. Froning;Michael J. Hickey;Stephen Antonysamy;Brian Kuhlman;
2024
2024, vol.16, no.7
The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras
Brian Kelley;
2024
2024, vol.16, no.7
Early determination of potential critical quality attributes of therapeutic antibodies in developability studies through surface plasmon resonance-based relative binding activity assessment
Shuai Wang;Yanqiu Wang;Zhenzhen Li;Ye Hong;Zhaohui Wang;Jiteng Fan;Qiong Wang;Yuanjie Ge;Xiaofeng Zhao;Guangcun Cheng;Changyan Chen;Yadan Wu;Yayuan Fu;
2024
2024, vol.16, no.7
国家科技图书文献中心
全球文献资源网
京ICP备05055788号-26
京公网安备11010202008970号 机械工业信息研究院 2018-2026